DaVita Inc.
New York Stock Exchange•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Company Description
- CEO
- Mr. Javier J. Rodriguez
- Full Time Employees
- 70,000
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Address
- 2000 16th Street Denver CO United States of America 80202
- IPO Date
- Oct 31, 1995
- CIK
- 0000927066
- Website
- davita.com
- Similar Companies
- Business
- DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Company News
DaVita Inc. Schedules 3rd Quarter 2024 Investor Conference Call
DaVita Stock Gains 47.3% Year to Date: What's Behind the Rally?
DaVita Prepares Thousands of Dialysis Patients for Hurricane Milton
Here's Why You Should Add DaVita Stock to Your Portfolio Now
Why DaVita HealthCare (DVA) is a Top Growth Stock for the Long-Term
This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar
5 Stocks Trading Near 52-Week High With Room to Rise Further
DaVita HealthCare (DVA) Advances While Market Declines: Some Information for Investors
Should Value Investors Buy DaVita (DVA) Stock?
Is DaVita (DVA) Stock Outpacing Its Medical Peers This Year?
DaVita Stock Rallies 17% in 3 Months: Is it Still Worth Buying?
Are You Looking for a Top Momentum Pick? Why DaVita HealthCare (DVA) is a Great Choice
Why DaVita HealthCare (DVA) is a Top Momentum Stock for the Long-Term
3 Stocks Warren Buffett Owns More Than 10% of Right Now
Here's Why DaVita HealthCare (DVA) Fell More Than Broader Market
DaVita HealthCare (DVA) Stock Falls Amid Market Uptick: What Investors Need to Know
DaVita Accelerates Commitment to Community Health with Nationwide Tour
5 Stocks to Benefit From Relative Price Strength Trends
3 Red Hot Stocks Flashing Buy Signals: DVA, ISRG, SN
DaVita Inc. (DVA) Soars to 52-Week High, Time to Cash Out?